Olympus 2013 Annual Report Download - page 21

Download and view the complete annual report

Please find page 21 of the 2013 Olympus annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 59

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59

38 OLYMPUS Annual Report 2013 39OLYMPUS Annual Report 2013
Review of Business Segments
(Millions of yen)
Years ended March 31 2011 2012 2013
Operating Results
Net Sales 100,808 92,432 85,513
Operating Expenses 92,255 86,993 81,986
Operating Income 8,553 5,439 3,527
Operating Margin (%) 8.5 5.9 4.1
Sales by Product
Life Science 44,464 42,650 38,910
Domestic 10,550 10,560 10,315
Overseas 33,914 32,090 28,595
Industrial 56,344 49,782 46,603
Domestic 20,564 8,394 7,526
Overseas 35,780 41,388 39,077
Segment Data
R&D Expenditures (¥ Billion) 10.4 8.7 8.2
Capital Expenditures (¥ Billion) 3.9 4.3 3.4
Number of Employees* 5,099 5,150 4,575
* Including average number of temporary employees
In the life science fi eld, tremendous strides are being made toward the realization of next-generation healthcare by
clarifying the unrevealed mechanisms of brain, pathogeny and metastasis of cancer, and drug action and immune
response. Olympus supports such research with bio-imaging technologies for the visualization of the movement and
activity of molecules within organisms.
In the industrial fi eld, in the area of non-destructive testing, Olympus supports public infrastructure safety and
security and contributes to R&D and quality improvement in production by offering industrial endoscopes, ultrasonic
fl aw detectors, eddy current fl aw detectors, and X-ray diffraction analyzers. Olympus meets wide-ranging needs in
the area of industrial microscopes, where rigorous observation, measurement, and control have become increasingly
important for responding to the higher density of electronic component and semiconductor packaging technologies.
Main Areas and Products
Composition (Fiscal year ended March 31, 2013)
Life Science
Upright microscopes and polarizing
microscopes, inverted microscopes,
laser confocal microscopes, box-type
fl uorescence imaging devices, stereo
microscopes, fl uorescence macro-
microscopes, microscope digital
cameras, imaging software, bio-imaging
systems, virtual slide systems
Industrial
Metallurgical microscopes, semi-
conductor inspection microscopes, laser
microscopes, measuring microscopes,
microscopic 3D measurement systems,
industrial videoscopes, industrial
fi berscopes, industrial rigid scopes,
ultrasonic fl aw detectors, eddy current
fl aw detectors, phased array fl aw
detectors, X-ray diffraction analyzers,
peripheral equipment
11.5%
Japan
20.9%
North America
24.5%
Europe
22.4%
Asia /
Oceania
24.4%
Others
7.8%
Life Science
45.5%
LIFE SCIENCE &
INDUSTRIAL
BUSINESS
Industrial
54.5%
Share of
Net Sales
(Consolidated net sales)
Share of
Net Sales
by Product
Share of
Net Sales
by Region
IX83 research inverted microscope
FLUOVIEW FVMPE-RS multi photon
laser scanning microscope
IPLEX TX industrial videoscope
Opto-Digital Microscope DSX100
(high-performance model)
45MG ultrasonic thickness gage
OmniScan SX PA ultrasonic phased
array flaw detector